Balchem (NASDAQ:BCPC) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a report issued on Thursday.

BCPC has been the topic of a number of other research reports. HC Wainwright set a $140.00 target price on Balchem and gave the company a “buy” rating in a report on Monday, October 15th. Sidoti raised Balchem from a “neutral” rating to a “buy” rating and set a $127.00 price target on the stock in a research note on Tuesday. ValuEngine raised Balchem from a “hold” rating to a “buy” rating in a research note on Thursday, August 30th. Finally, Pivotal Research increased their price target on Balchem from $85.00 to $95.00 and gave the stock a “hold” rating in a research note on Friday, August 3rd. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $120.67.

Shares of NASDAQ:BCPC opened at $100.28 on Thursday. The firm has a market cap of $3.25 billion, a price-to-earnings ratio of 39.64 and a beta of 0.83. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.82 and a current ratio of 3.98. Balchem has a one year low of $70.23 and a one year high of $117.79.

Balchem (NASDAQ:BCPC) last announced its earnings results on Friday, August 3rd. The basic materials company reported $0.76 EPS for the quarter, beating analysts’ consensus estimates of $0.75 by $0.01. The firm had revenue of $163.70 million for the quarter, compared to analysts’ expectations of $163.20 million. Balchem had a return on equity of 13.78% and a net margin of 15.28%. The business’s revenue for the quarter was up 11.3% on a year-over-year basis. As a group, equities research analysts forecast that Balchem will post 2.45 earnings per share for the current year.

Several institutional investors have recently modified their holdings of BCPC. Wells Fargo & Company MN lifted its stake in shares of Balchem by 5.6% during the 1st quarter. Wells Fargo & Company MN now owns 78,864 shares of the basic materials company’s stock worth $6,447,000 after purchasing an additional 4,195 shares during the period. JPMorgan Chase & Co. raised its position in shares of Balchem by 20.6% in the 1st quarter. JPMorgan Chase & Co. now owns 73,196 shares of the basic materials company’s stock worth $5,985,000 after buying an additional 12,487 shares during the period. Dimensional Fund Advisors LP raised its position in shares of Balchem by 0.4% in the 1st quarter. Dimensional Fund Advisors LP now owns 733,707 shares of the basic materials company’s stock worth $59,981,000 after buying an additional 2,775 shares during the period. Russell Investments Group Ltd. raised its position in shares of Balchem by 10.4% in the 1st quarter. Russell Investments Group Ltd. now owns 92,893 shares of the basic materials company’s stock worth $7,594,000 after buying an additional 8,734 shares during the period. Finally, Principal Financial Group Inc. raised its position in shares of Balchem by 3.1% in the 1st quarter. Principal Financial Group Inc. now owns 259,217 shares of the basic materials company’s stock worth $21,190,000 after buying an additional 7,782 shares during the period. 88.21% of the stock is currently owned by institutional investors.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.

Featured Story: What is a conference call?

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.